STOCK TITAN

CURIS INC (CRIS) director granted 6,800 non-qualified stock options at $5.29

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CURIS INC director Anne Elizabeth Borgman received a grant of non-qualified stock options, acquiring rights to purchase 6,800 shares of common stock at an exercise price of $5.29 per share. These options vest 100% on July 7, 2027 and expire on July 6, 2036. Following this grant, her reported derivative holdings from this award total 6,800 options, reflecting compensation-related equity rather than an open-market purchase.

Positive

  • None.

Negative

  • None.
Insider Borgman Anne Elizabeth
Role null
Type Security Shares Price Value
Grant/Award Non Qualified Stock Option 6,800 $5.29 $36K
Holdings After Transaction: Non Qualified Stock Option — 6,800 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 6,800 options Non-qualified stock option grant to director on July 7, 2026
Exercise price $5.29 per share Strike price for 6,800 non-qualified stock options
Underlying shares 6,800 shares Common stock underlying the option grant
Vesting date July 7, 2027 100% of underlying shares vest on this date
Expiration date July 6, 2036 Option term end for this grant
Derivative holdings after grant 6,800 options Total options reported following transaction
Non Qualified Stock Option financial
"security_title: "Non Qualified Stock Option""
vesting financial
"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "5.2900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-07-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did CURIS INC (CRIS) director Anne Borgman report in this Form 4?

Anne Elizabeth Borgman reported receiving a grant of non-qualified stock options for 6,800 shares of CURIS INC common stock. The options were awarded as compensation, not bought on the open market, and are tied to future vesting conditions and a long-dated expiration.

How many CURIS INC (CRIS) options were granted to Anne Borgman and at what price?

She was granted non-qualified stock options covering 6,800 shares of CURIS INC common stock at an exercise price of $5.29 per share. This price is the amount she would pay per share if she chooses to exercise the options after they vest.

When do Anne Borgman’s CURIS INC (CRIS) stock options vest and expire?

The option grant vests as to 100% of the underlying 6,800 shares on July 7, 2027. The options have an expiration date of July 6, 2036, after which any unexercised options will no longer be exercisable.

Are Anne Borgman’s CURIS INC (CRIS) option transactions open-market buys or compensation?

The Form 4 shows a transaction code "A" classified as a grant or award acquisition, meaning the 6,800 options were granted as compensation. This is not an open-market purchase and does not reflect a discretionary buy in the market.

How many CURIS INC (CRIS) options does Anne Borgman hold after this grant?

Following the reported grant, her total derivative holdings from this award are 6,800 non-qualified stock options. These options relate to an equal number of underlying common shares and become exercisable only after the full vesting date in 2027.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Borgman Anne Elizabeth

(Last)(First)(Middle)
128 SPRING STREET
BUILDING C - SUITE 500

(Street)
LEXINGTON MASSACHUSETTS 02421

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CURIS INC [ CRIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non Qualified Stock Option$5.2907/07/2026A6,800 (1)07/06/2036Common Stock6,800$5.296,800D
Explanation of Responses:
1. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.
Remarks:
Exhibit Index: 24.1 Power of Attorney
/s/ Diantha Duvall, Attorney-in-fact07/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)